¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ KGOG 2022 Fall Semi-annual meeting 2ÀÏÂ÷ : 2022-11-19

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ KGOG 2022 Fall Semi-annual meeting 2ÀÏÂ÷ : 2022-11-19
±³À°ÀÏÀÚ : 2022-11-19
±³À°Àå¼Ò : ¼ÛµµÄÁº¥½Ã¾Æ  
±³À°ÁÖÁ¦ : KGOG 2022 Fall Semi-annual meeting 2ÀÏÂ÷
ÁÖÃÖ±â°ü : ´ëÇѺÎÀÎÁ¾¾çÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸  
´ã´çÀÚ : ±èÀμ÷
¿¬¶ôó : 02-512-5420  
À̸ÞÀÏ : kiskgog@hanmail.net      
±³À°Á¾·ù : »êºÎÀΰú      
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ÀÎõ±¤¿ª½Ã
±³À°½Ã°£ : 7 ½Ã°£ 5ºÐ  
¼¼ºÎ¼ö°­·á : 50,000¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-19 Room A 09:00~09:10 Introduction/Review of on-going studies  ÃÖÇöÁø(Á߾Ӵ뱤¸íº´¿ø) 
±³À°½Ã°£ 11-19 Room A 09:10~09:30 Management, Surveillance and Clinical course of Women diagnosed with  ±èº¸¶ó(ÀÌ´ë¸ñµ¿º´¿ø) 
Åä·Ð 11-19 Room A 09:30~09:40 Discussion  () 
±³À°½Ã°£ 11-19 Room A 09:40~10:00 . Randomized Phase III Trial of HIPEC in Platinum-Resistant Recurrent Ovarian  ÀÓ¸íö(±¹¸³¾Ï¼¾ÅÍ) 
Åä·Ð 11-19 Room A 10:00~10:10 Discussion  () 
±³À°½Ã°£ 11-19 Room A 10:10~10:30 Randomized Phase 2 trial of Cytoreductive Surgery for PARPi-Resistant Recurrent  Á¶Çö¿õ(°í´ë±¸·Îº´¿ø) 
Åä·Ð 11-19 Room A 10:30~10:40 Discussion  () 
±³À°½Ã°£ 11-19 Room A 11:00~11:05 Summary & Update of KGOG 1047/DEBULK  ³ëÁÖ¿ø(ÀÏ»êÂ÷º´¿ø) 
±³À°½Ã°£ 11-19 Room A 11:05~11:15 New techniques of definitive radiotherapy in cervical cancer : does it matter?  ¾ö±Ù¿ë(ºÐ´ç¼­¿ï´ëº´¿ø) 
±³À°½Ã°£ 11-19 Room A 11:15~11:25 Process of RTQC  °­»ó¿ø(ºÐ´ç¼­¿ï´ëº´¿ø) 
±³À°½Ã°£ 11-19 Room A 11:25~11:35 Know-how for successful international collaboration  ³²º´È£(Ç층½º) 
±³À°½Ã°£ 11-19 Room A 11:35~11:45 Future Revision, Troubleshooting & Expected Performance  ³ëÁÖ¿ø(ÀÏ»êÂ÷º´¿ø) 
±³À°½Ã°£ 11-19 Room A 12:00~12:25 Latest update of Olaparib in 1L maintenance therapy in advanced ovarian cancer  ³ëÀçÈ«(ºÐ´ç¼­¿ï´ëº´¿ø) 
±³À°½Ã°£ 11-19 Room A 12:25~12:50 Consideration of choosing combination therapy with Olaparib and bevacizumab  ÀÌÀ¯¿µ(»ï¼º¼­¿ïº´¿ø) 
±âŸ 11-19 Room A 13:00~13:03 Introduction  À̱ÙÈ£(¼­¿ï¼º¸ðº´¿ø) 
±³À°½Ã°£ 11-19 Room A 13:10~13:20 Review of recent clinical trials in cervical cancer-ESMO Congress 2022  À̼ºÁ¾(¼­¿ï¼º¸ðº´¿ø) 
±³À°½Ã°£ 11-19 Room A 13:20~13:30 Review of recent clinical trials in cervical cancer-NRG 2022 Summer meeting  ÀåÇϱÕ(°í´ë¾È»êº´¿ø) 
±³À°½Ã°£ 11-19 Room A 13:30~13:40 Review of recent clinical trials in cervical cancer-ASCO 2022 Annual meeting  ³ëÁØÈ£(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 11-19 Room A 13:40~13:45 Overview of ongoing study  Á¤¿ë¿í(°­³²Â÷º´¿ø) 
±³À°½Ã°£ 11-19 Room A 13:45~13:50 . KGOG 1043/ENGOT-CX12 A randomized, Open-Lable, Phase 3 Trial of  À̼ºÁ¾(¼­¿ï¼º¸ðº´¿ø) 
±³À°½Ã°£ 11-19 Room A 13:50~13:55 . KGOG 1044/SELPAX-1 Multi-center prospective study for human papilloma  ±è¹®È«(¿øÀڷº´¿ø) 
±³À°½Ã°£ 11-19 Room A 13:55~14:00 . KGOG 1046/AFTER Adjuvant Chemotherapy Versus Radiotherapy For  ½É½ÂÇõ(°Ç±¹´ëº´¿ø) 
±³À°½Ã°£ 11-19 Room A 14:00~14:05 . KGOG 1047/DEBULK Therapeutic effect of surgical debulking of metastatic  ³ëÁÖ¿ø(ÀÏ»êÂ÷º´¿ø) 
±³À°½Ã°£ 11-19 Room A 14:05~14:10 . KGOG 1048 Prediction model for survival and recurrence in early-stage  ±è´ë¿¬(¼­¿ï¾Æ»êº´¿ø) 
±³À°½Ã°£ 11-19 Room A 14:10~14:25 . RTQA (Radiation Therapy Quality Assurance) presentation  ±è¿ë¹è(¼¼ºê¶õ½ºº´¿ø) 
±³À°½Ã°£ 11-19 Room A 14:25~14:35 . Tisotumab Vedotin for the cervical cancer  ¹éÁöÈì(¾ÆÁִ뺴¿ø) 
±³À°½Ã°£ 11-19 Room A 14:35~14:45 . Next drugs: Pembrolizum  Àü¼·(¼øõÇâõ¾Èº´¿ø) 
±³À°½Ã°£ 11-19 Room A 14:45~15:00 . Imiquimod as an alternative treatment for preinvasive lesion of the uterine  Á¤¿ë¿í(°­³²Â÷º´¿ø) 
±âŸ 11-19 Room A 15:00~15:01 Introduction  ¼Û¿ëÁß(¾ç»êºÎ»ê´ëº´¿ø) 
±³À°½Ã°£ 11-19 Room A 15:01~15:06 KGOG 4004(OVsurg-2102-1): A survey on peritonectomy procedure in debulking  ±è¸í¼±(¼ººó¼¾Æ®º´¿ø) 
±³À°½Ã°£ 11-19 Room A 15:06~15:11 KGOG 4005 (OVsurg-2101): The analysis of the patients who have received  ÀÓ¸íö(±¹¸³¾Ï¼¾Å¸) 
±³À°½Ã°£ 11-19 Room A 15:11~15:16 KGOG 4006 (OVsurg-2103): The analysis of 90-day postoperative mortality  ¼Û¿ëÁß(¾ç»êºÎ»ê´ëº´¿ø) 
±³À°½Ã°£ 11-19 Room A 15:16~15:21 KGOG 4010 (OVsurg-2108): Assessment of QoL after LAR or visceral peritoneal  ¹Ú¼öÁø(¼­¿ï´ëº´¿ø) 
±³À°½Ã°£ 11-19 Room A 15:21~15:31 OVsurg-2109: A Proper intervention of pleural metastasis in stage IV epithelial  ÀÌÀºÁö(Á߾Ӵ뺴¿ø) 
±³À°½Ã°£ 11-19 Room A 16:00~16:15 Summary of study status  º¯È­°æ(¼¼ºê¶õ½ºº´¿ø) 
±³À°½Ã°£ 11-19 Room A 16:15~16:30 Trial specific RT-QA  ±èÈ£Áø(¿¬¼¼¾Ïº´¿ø) 
±³À°½Ã°£ 11-19 Room A 16:30~16:40 Future direction and strategy of trial  ±è¿ë¹è(¼¼ºê¶õ½ºº´¿ø) 
±³À°½Ã°£ 11-19 Room A 17:00~17:25 Optimal management of Febrile Neutropenia of Ovarian Cancer  ±èÁöÇü(°­³²¼¼ºê¶õ½ºº´¿ø) 
±³À°½Ã°£ 11-19 Room A 17:25~17:50 Treatment of neutropenia in ovarian cancer  ¾çÀºÁ¤(¼øõÇâõ¾Èº´¿ø) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ KGOG 2022 Fall Semi-annual meeting 2ÀÏÂ÷ : 2022-11-19""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2022³â ´ëÇÑôÃß¿Ü°úÇÐȸ Á¦ 39Â÷ Ãß°èÇмú´ëȸ 2ÀÏÂ÷ : 2022-11-19
´ÙÀ½±Û °­¿øµµ ½Å±Ô ¹× ±âÁ¸°³¼³ÀÇ·á±â°ü ´ë»ó ¼¼¹Ì³ª : 2022-11-19
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21088 ºÎ»ê 2024 ´ëÇѺñ¸¸ÇÐȸ ºÎ¿ï°æÁöȸ Ãá°è¿¬¼ö°­Á : 2024-07-06 0 4 12:27:32
21087 ¼­¿ï 2024 °­ºÏ»ï¼ºº´¿ø ¼ÒÈ­±â ½ÉÆ÷Áö¾ö : 2024-07-06 0 2 12:26:27
21086 ´ëÀü Çѱ¹È£½ºÇǽº¡¤¿ÏÈ­ÀÇ·áÇÐȸ 2024³â ÇÏ°èÇмú´ëȸ : 2024-07-06 0 4 12:24:03
21085 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø 2024 Á¶¿µÁ¦ ¾ÈÀü°ü¸® ½ÉÆ÷Áö¾ö : 2024-07-06 0 1 12:22:31
21084 ¼­¿ï Á¦22ȸ ¼­¿ï½Ã ³²¼­ 7°³±¸ ÀÇ»çȸ ÇÕµ¿ Çмú´ëȸ : 2024-07-06 0 0 12:21:04
21083 ±¤ÁÖ ±¤ÁÖÀü³²³»°úÀÇ»çȸ Á¦6ȸ ÃÊÀ½ÆÄ ÇÚÁî¿Â ¿öÅ©¼ó : 2024-07-06 0 1 12:19:46
21082 ¼­¿ï 2024 ´ëÇѹ®¸Æ¾ÐÇ×ÁøÁõ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-07-06 0 1 12:18:27
21081 °­¿ø 2024³â ´ëÇѳ»°úÇÐȸ °­¿øÁöȸ ÇÏ°è ¿¬¼ö°­Á : 2024-07-06 0 0 12:17:14
21080 °æ±â 2024³â °í´ë¾È»ê ³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-06 0 0 12:15:55
21079 ¼­¿ï 2024 È£Èí±â°¨¿°º´ ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-07-06 0 1 12:14:45
21078 ºÎ»ê ´ëÇÑÀ̺ñÀÎÈÄ°úÀÇ»çȸ 2024 Áöȸ&ÁöºÎ ½ÉÆ÷Áö¾ö-ºÎ¿ï°æ : 2024-07-06 0 1 12:12:14
21077 ¼­¿ï ´ëÇÑÅ»ÀåÇÐȸ 18th Congress of the KHS & 2024 International Symposium(2ÀÏÂ÷) : 2024-07-06 0 1 12:10:49
21076 ¼­¿ï ´ëÇÑ¿Ü°úÃÊÀ½ÆÄÇÐȸ 2024 Breast Biopsy Symposium : 2024-07-06 0 1 12:09:11
21075 ¼­¿ï 2024³â ´ëÇѼö¸é¿¬±¸ÇÐȸ Á¤±â Çмú´ëȸ DAY 1 : 2024-07-06 0 1 12:07:33
21074 ±¤ÁÖ 2024³âµµ ´ëÇÑÇǺΰúÀÇ»çȸ ±¤ÀüÁöºÎ ±³À°½ÉÆ÷Áö¿ò : 2024-07-06 0 1 12:03:12
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷